Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial.
Lee DH, Lee JS, Wang J, Hsia TC, Wang X, Kim J, Orlando M. Lee DH, et al. Among authors: kim j. Cancer Res Treat. 2015 Oct;47(4):616-29. doi: 10.4143/crt.2014.051. Epub 2014 Nov 24. Cancer Res Treat. 2015. PMID: 25672577 Free PMC article. Clinical Trial.
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial.
Kang JH, Ahn MJ, Kim DW, Cho EK, Kim JH, Shin SW, Wang X, Kim JS, Orlando M, Park K. Kang JH, et al. Among authors: kim dw, kim js, kim jh. Cancer Res Treat. 2016 Apr;48(2):458-64. doi: 10.4143/crt.2015.135. Epub 2015 Oct 14. Cancer Res Treat. 2016. PMID: 26511807 Free PMC article. Clinical Trial.
First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial.
Boye M, Wang X, Srimuninnimit V, Kang JH, Tsai CM, Orlando M, Puri T, Kim JS, Rajan N, Yang JC. Boye M, et al. Among authors: kim js. Clin Lung Cancer. 2016 Mar;17(2):150-60. doi: 10.1016/j.cllc.2015.12.004. Epub 2015 Dec 17. Clin Lung Cancer. 2016. PMID: 26809984 Free article. Clinical Trial.
Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study.
Tannir NM, Papadopoulos KP, Wong DJ, Aljumaily R, Hung A, Afable M, Kim JS, Ferry D, Drakaki A, Bendell J, Naing A. Tannir NM, et al. Among authors: kim js. Int J Cancer. 2021 Jul 15;149(2):403-408. doi: 10.1002/ijc.33556. Epub 2021 Mar 24. Int J Cancer. 2021. PMID: 33709428 Free PMC article. Clinical Trial.
16,482 results
You have reached the last available page of results. Please see the User Guide for more information.